
San Francisco Chronicle (12.30.01) - Monday, December 31, 2001
Carol Ness
If Kramer, by far the most high-profile person with HIV to undergo a transplant, continues to thrive with his new liver, he'll be a very visible boost to efforts to persuade more hospitals to allow organ transplants for people with HIV. Kramer, one of the world's original AIDS activists as founder of New York's Gay Men's Health Crisis, is at the cutting edge again with his transplant, performed Dec. 21 at the University of Pittsburgh Medical Center. He was only the 10th patient with HIV to get a new liver at the hospital's huge transplant center since new drug treatments for the virus vastly extended lives. Within five days, Kramer was out of intensive care and walking. By Friday he was being prepped for release, perhaps as early as this week.
People who once would have swiftly succumbed to AIDS now are living long enough that accompanying diseases - in Kramer's case, hepatitis B - can progress to the point of destroying their organs. So the need for transplants among people with HIV is rising, according to Dr. Michelle Roland at the University of California at San Francisco. She is co-leader of a national study of transplants in HIV-infected patients that will provide the first rigorous analysis of outcomes. As an HIV doctor, she hopes it will give the kind of information about survival and drug interactions that doctors say they need to start providing infected patients with transplants.
011231
AD012256
Copyright © 2001 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.